SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Guggenheim Securities Downgrades Abbott Laboratories to Neutral

Guggenheim Securities analyst Christopher Pasquale downgrades Abbott Laboratories (NYSE:ABT) from Buy to Neutral.

Benzinga · 01/02/2020 12:17

Guggenheim Securities analyst Christopher Pasquale downgrades Abbott Laboratories (NYSE:ABT) from Buy to Neutral.